Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Cell Analysis Products
  4. Cell Based Assays
  5. Cell Growth and Differentiation Reagents and Kits
  6. Promega ApoLive-Glo™ Multiplex Assay

Promega ApoLive-Glo™ Multiplex Assay

Catalog No. PRG6410 Shop All Promega Corporation Products
Change view
Click to view available options
Quantity:
10 mL
5 x 10 mL
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PRG6410 10 mL
PRG6411 5 x 10 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. PRG6410 Supplier Promega Supplier No. G6410
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Includes

GF-AFC Substrate, Assay Buffer, Caspase-Glo 3/7 Buffer, Caspase-Glo 3/7 Substrate

The ApoLive-Glo™ Multiplex Assay measures both the number of viable cells as a marker of cytotoxicity and caspase activation as a marker of apoptosis within a single assay well to determine the mechanism of cell death.

  • Measure Viability and Apoptosis in the Same Sample Well
  • Accurately determine mechanism of cell death in less time, with less sample
  • Easy to implement using a simple sequential 'add-mix-measure' protocol
  • Adaptable to meet various throughput needs

Specifications

Quantity 10 mL
Detection Method Fluorescence, Luminescence
For Use With (Application) Profile Compounds for Cytotoxic Risk
Kit Contents 1 x 10 μL GF-AFC substrate, 1 x 10 mL Assay Buffer, 1 x 10 mL Caspase-Glo 3/7 Buffer, 1 x 1 bottle Caspase-Glo 3/7 substrate
Format Bottle
Content And Storage -30°C to -10°C

  • U.S. Patents 7,416,854; 7,553,632 and other patents pending.
  • U.S. Patents 6,602,677 and 7,241,584, Australian Patents 754312 and 785294 and other patents and patents pending.
  • U.S. Patents 7,148,030 and 7,384,758, Australian Patent 2003216139 and other patents pending.
  • The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024, 5,674,713 and 5,700,673.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.